Trial · NCT00266110
Adverse events42
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 42
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Albumin, serum-low (hypoalbuminemia) | Metabolism and nutrition disorders | Dendritic Cell Vaccine | 1 | 17 | |
| other | Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip) | Respiratory, thoracic and mediastinal disorders | Dendritic Cell Vaccine | 1 | 17 | |
| other | ALT, SGPT (serum glutamic pyruvic transaminase) | Investigations | Dendritic Cell Vaccine | 1 | 17 | |
| other | Anorexia | Metabolism and nutrition disorders | Dendritic Cell Vaccine | 1 | 17 | |
| other | AST, SGOT(serum glutamic oxaloacetic transaminase) | Investigations | Dendritic Cell Vaccine | 1 | 17 | |
| other | Calcium, serum-low (hypocalcemia) | Metabolism and nutrition disorders | Dendritic Cell Vaccine | 3 | 17 | |
| other | Creatinine | Investigations | Dendritic Cell Vaccine | 1 | 17 | |
| other | Diarrhea | Gastrointestinal disorders | Dendritic Cell Vaccine | 1 | 17 | |
| other | Dyspnea (shortness of breath) | Respiratory, thoracic and mediastinal disorders | Dendritic Cell Vaccine | 2 | 17 | |
| other | Fatigue (asthenia, lethargy, malaise) | General disorders | Dendritic Cell Vaccine | 6 | 17 | |
| other | Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L) | General disorders | Dendritic Cell Vaccine | 1 | 17 | |
| other | Glucose, serum-high (hyperglycemia) | Metabolism and nutrition disorders | Dendritic Cell Vaccine | 2 | 17 | |
| other | Heartburn/dyspepsia | Gastrointestinal disorders | Dendritic Cell Vaccine | 1 | 17 | |
| other | Hemoglobin | Blood and lymphatic system disorders | Dendritic Cell Vaccine | 5 | 17 | |
| other | Hypotension | Vascular disorders | Dendritic Cell Vaccine | 1 | 17 | |
| other | Infection with normal ANC or Grade 1 or 2 neutrophils - Abdomen NOS | Infections and infestations | Dendritic Cell Vaccine | 1 | 17 | |
| other | Infection with normal ANC or Grade 1 or 2 neutrophils - Upper airway NOS | Infections and infestations | Dendritic Cell Vaccine | 1 | 17 | |
| other | Injection site reaction/extravasation changes | General disorders | Dendritic Cell Vaccine | 1 | 17 | |
| other | Insomnia | Psychiatric disorders | Dendritic Cell Vaccine | 1 | 17 | |
| other | Leukocytes (total WBC) | Investigations | Dendritic Cell Vaccine | 4 | 17 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00266110/events